✦ LIBER ✦

Infliximab for Intensification of Primary Therapy for Kawasaki Disease: A Phase 2 Randomised, Double-Blind, Placebo-Controlled Trial

✍ Scribed by Nordeen, Claire

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infliximab for intensification of primar

✍ Tremoulet, Adriana H; Jain, Sonia; Jaggi, Preeti; Jimenez-Fernandez, Susan; Panc 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 185 KB

Doxycycline in Creutzfeldt-Jakob disease

✍ Haïk, Stéphane; Marcon, Gabriella; Mallet, Alain; Tettamanti, Mauro; Welaratne, 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 280 KB

A double blind randomised placebo contro

✍ G. T. Sunderland; J. J. F. Belch; R. D. Sturrock; C. D. Forbes; A. J. McKay 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 277 KB

Siltuximab for multicentric Castleman's

✍ van Rhee, Frits; Wong, Raymond S; Munshi, Nikhil; Rossi, Jean-Francois; Ke, Xiao 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 485 KB

Firategrast for relapsing remitting mult

✍ David H Miller; Thomas Weber; Richard Grove; Claire Wardell; Joseph Horrigan; Ol 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 267 KB

TAS-102 monotherapy for pretreated metas

✍ Takayuki Yoshino; Nobuyuki Mizunuma; Kentaro Yamazaki; Tomohiro Nishina; Yoshito 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 286 KB